AI’s bioweapon: Scientists use AI to design viruses, raising alarms over AI misuse
Stanford researchers used AI to design blueprints for 16 bacteriophages that kill antibiotic-resistant E. coli. While offering promise for new treatments, the breakthrough raises dual-use concerns about AI potentially being misused to engineer harmful pathogens in unsafe hands
Hyderabad: What if Artificial Intelligence (AI) tools at the wrong hands are used to repurpose harmful human pathogens or even improve the existing ones like Covid or Small Pox and unleash them on the population?
A first-of-its-kind breakthrough from scientists of Stanford University, in which they utilised two AI models to design blueprints of 16 viruses that are capable of attacking E Coli in a laboratory setting, has set-off similar concerns related to dual-use dilemma, a scenario in which AI is simultaneously very good and potentially even concerning.
The computational researchers from Stanford University, in a study that is available in pre-print at bioRxiv.og (September, 2025) and yet to be fully peer-reviewed, have indicated that they have developed viruses that are stopping virus-resistant E.Coli strains from growing, suggesting that the technique could be help scientists develop newer therapies capable of treating more complex diseases.
Computational biologist from Stanford University, Brian Hie, who has been quoted by multiple agencies, indicated that such work is a step towards using the technology to design living organisms that are capable of fighting-off pathogens.
According to reports, the scientists utilised two of their AI models to create genomes for bacteria-killing viruses. The AI models ended up creating models of viruses called bacteriophages that specifically attack and kill bacteria. These viruses do not infect human cells, making them safe for potential human treatments.
The researchers developed a complete genetic genome (blueprint) for these viruses from scratch and when synthesized in the lab and tested, some of the AI-designed phages were found to be more effective and faster in killing E-Coli strains.
The breakthrough has the potential in the field of emerging medicine to treat dangerous bacterial infections that are no longer treatable from antibiotics, because of antimicrobial resistance.
